The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women: A Double-blind, Randomized, Placebo-Controlled Trial
Open accessAbstract
BACKGROUND: Results of previous studies suggest that estrogen improves somatic and mild depressive symptoms experienced by perimenopausal women. This study investigated the efficacy of 17beta-estradiol for the treatment of clinically significant depressive disorders in endocrinologically confirmed perimenopausal women. METHODS: Perimenopausal women (aged 40-55 years, with irregular menstrual periods and serum concentrations of follicle-stimulating hormone >25 IU/L), meeting criteria for major depressive disorder, dysthymic disorder, or minor depressive disorder, according to DSM-IV, were randomized to receive transdermal patches of 17beta-estradiol (100 microgram) or placebo in a 12-week, double-blind, placebo-controlled study. A 4-week washout period followed the 12-week treatment phase. Outcome measures were the Montgomery-Asberg Depression Rating Scale and Blatt-Kupperman Menopausal Index scores. RESULTS: Fifty women were enrolled in the study; 26 met DSM-IV criteria for major depressive disorder, 11 for dysthymic disorder, and 13 for minor depressive disorder. Remission of depression was observed in 17 (68%) women treated with 17beta-estradiol compared with 5 (20%) in the placebo group (P =.001). Subjects responded similarly to estradiol treatment, regardless of DSM-IV diagnosis. Patients treated with estradiol sustained antidepressant benefit of treatment after the 4-week washout period, although somatic complaints increased in frequency and intensity. Treatment was well tolerated and adverse events were rare in both groups. CONCLUSION: Transdermal estradiol replacement is an effective treatment of depression for perimenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Spitzer, R. L., Williams, J. B. W., Kroenke, K., Hornyak, R., & McMurray, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106580 · Cited by 847 · cited 1×
“The recruitment of subjects with depression who primarily sought treatment for physical symptoms in a gynecological outpatient clinic appears to be appropriate and consistent with previous reports showing that depressive disorders are frequently encountered in medical care settings.(40,41) In addition, their first app…”
ResultEstrogen replacement in perimenopause-related depression: A preliminary report
Schmidt, P. J., Nieman, L., Danaceau, M. A., Tobin, M. B., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106004 · Cited by 578
Transdermal oestrogen for treatment of severe postnatal depression
Gregoire, A. J. P., Kumar, R., Everitt, B., & Studd, J. W. W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91414-2 · Cited by 562
Oestrogen Therapy and the Menopausal Syndrome
CAMPBELL, S., & WHITEHEAD, M. (1977) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00374-5 · Cited by 539
Avis, N. E., Brambilla, D., McKinlay, S. M., & Vass, K. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90099-x · Cited by 482
Ovarian steroids and the brain: Implications for cognition and aging
McEwen, B. S., Alves, S. E., Bulloch, K., & Weiland, N. G. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.8s · Cited by 482
Cited by
Sex differences in anxiety and depression clinical perspectives
Altemus, M., Sarvaiya, N., & Neill Epperson, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.004 · Cited by 1,413
“In addition, two randomized clinical trials (Schmidt et al., 2000; Soares et al., 2001) indicate that typical hormone therapy doses of estradiol (50 or 100 lg/d) are significantly more effective than placebo in treating major depression with perimenopause onset, a finding that is lacking for major…”
BackgroundThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
“, 2002), is a promising treatment of depression (Dayas et al., 2000; Fink et al., 1996; Gregoire et al., 1996; Soares et al., 2001).”
BackgroundFreeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.375 · Cited by 893
Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.385 · Cited by 831
Self-citationThe 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Sex differences in stress-related psychiatric disorders: neurobiological perspectives
Bangasser, D. A., & Valentino, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.008 · Cited by 737
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Rutter, M., Caspi, A., & Moffitt, T. E. (2003) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00194 · Cited by 672
Menopausal Symptoms and Their Management
Santoro, N., Epperson, C. N., & Mathews, S. B. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.05.001 · Cited by 645
Hormones and Menopausal Status as Predictors of Depression in Womenin Transition to Menopause
Freeman, E. W., Sammel, M. D., Liu, L., Gracia, C. R., Nelson, D. B., & Hollander, L. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.62 · Cited by 636
Hormones and mood: from menarche to menopause and beyond
Steiner, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00432-9 · Cited by 558
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 505
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001833 · Cited by 490
Walf, A. A., & Frye, C. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301067 · Cited by 461
Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
Morrison, J. H., Brinton, R. D., Schmidt, P. J., & Gore, A. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3369-06.2006 · Cited by 386
Takahashi, T. A., & Johnson, K. M. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.006 · Cited by 355
Soares, C. N., & Zitek, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0831 · Cited by 350
Dalal, P., & Agarwal, M. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161483 · Cited by 349
Serotonin and brain development
Sodhi, M. S. K., & Sanders-Bush, E. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 340
Sex differences in the psychopharmacological treatment of depression
Sramek, J. J., Murphy, M. F., & Cutler, N. R. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/ncutler · Cited by 339
Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M., Avis, N. E., Gold, E. B., Randolph, J. F., & Matthews, K. A. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.55 · Cited by 320
Increased anxiety and synaptic plasticity in estrogen receptor β-deficient mice
Krȩżel, W., Dupont, S., Krust, A., Chambon, P., & Chapman, P. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451898 · Cited by 278
Gordon, J. L., Girdler, S. S., Meltzer-Brody, S. E., Stika, C. S., Thurston, R. C., Clark, C. T., Prairie, B. A., Moses-Kolko, E., Joffe, H., & Wisner, K. L. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070918 · Cited by 274
Self-citationGrigoriadis, S., & Robinson, G. E. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653294 · Cited by 272
Deecher, D., Andree, T. H., Sloan, D., & Schechter, L. E. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.10.006 · Cited by 270
Hormonal Treatments for Major Depressive Disorder: State of the Art
Dwyer, J. B., Aftab, A., Radhakrishnan, R., Widge, A., Rodriguez, C. I., Carpenter, L. L., Nemeroff, C. B., McDonald, W. M., Kalin, N. H., & APA Council of Research Task Force on Novel Biomarkers and Treatments (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19080848 · Cited by 252
Estrogen Levels Are Associated with Extinction Deficits in Women with Posttraumatic Stress Disorder
Glover, E. M., Jovanovic, T., Mercer, K. B., Kerley, K., Bradley, B., Ressler, K. J., & Norrholm, S. D. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.031 · Cited by 259
Almeida, O. P., Waterreus, A., Spry, N., Flicker, L., & Martins, R. N. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.11.002 · Cited by 255
Self-citationSchmidt, P. J., Ben Dor, R., Martinez, P. E., Guerrieri, G. M., Harsh, V. L., Thompson, K., Koziol, D. E., Nieman, L. K., & Rubinow, D. R. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0111 · Cited by 255
Estrogen in Severe Mental Illness: A Potential New Treatment Approach
Kulkarni, J., de Castella, A., Fitzgerald, P. B., Gurvich, C. T., Bailey, M., Bartholomeusz, C., & Burger, H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.8.955 · Cited by 254
Anxiety Disorders Among Women: A Female Lifespan Approach
Hantsoo, L., & Epperson, C. N. (2017) · Focus · doi:10.1176/appi.focus.20160042 · Cited by 183
Antidepressant effects of ERβ-selective estrogen receptor modulators in the forced swim test
Walf, A. A., Rhodes, M. E., & Frye, C. A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.023 · Cited by 179
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment
Flores, V. A., Pal, L., & Manson, J. E. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab011 · Cited by 174
Effects of estrogen variation on neural correlates of emotional response inhibition
Amin, Z., Epperson, C. N., Constable, R. T., & Canli, T. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.03.013 · Cited by 163
Almeida, O. P., Yeap, B. B., Hankey, G. J., Jamrozik, K., & Flicker, L. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.33 · Cited by 158
Self-citationSex differences in stress responses: focus on ovarian hormones
Ter Horst, G. J., Wichmann, R., Gerrits, M., Westenbroek, C., & Lin, Y. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.036 · Cited by 157
Female hormones affect symptom severity in obsessive–compulsive disorder
Vulink, N. C. C., Denys, D., Bus, L., & Westenberg, H. G. M. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000199454.62423.99 · Cited by 123
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
Marsh, W. K., Templeton, A., Ketter, T. A., & Rasgon, N. L. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.12.006 · Cited by 48
Green, S. M., Key, B. L., & McCabe, R. E. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.10.004 · Cited by 41
Women's mental health research: The emergence of a biomedical field
Blehar, M. C. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095344 · Cited by 36
The impact of traumatic brain injury on pituitary function
Sundaram, N. K., Geer, E. B., & Greenwald, B. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.003 · Cited by 22
Metadata
- Authors
- de Novaes Soares, C., Almeida, O. P., Joffe, H., & Cohen, L. S.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2001-06-01
- Volume
- 58
- Issue
- 6
- Pages
- 529
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2142604492
- Cited by
- 691
- References
- 36
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.